Authors:
LIEGLER TJ
YONEMOTO W
ELBEIK T
VITTINGHOFF E
BUCHBINDER SP
GREENE WC
Citation: Tj. Liegler et al., DIMINISHED SPONTANEOUS APOPTOSIS IN LYMPHOCYTES FROM HUMAN IMMUNODEFICIENCY VIRUS-INFECTED LONG-TERM NONPROGRESSORS, The Journal of infectious diseases, 178(3), 1998, pp. 669-679
Authors:
LATHEY JL
HUGHES MD
FISCUS SA
PI T
JACKSON JB
RASHEED S
ELBEIK T
REICHMAN R
JAPOUR A
DAQUILA RT
SCOTT W
GRIFFITH BP
HAMMER SM
KATZENSTEIN DA
Citation: Jl. Lathey et al., VARIABILITY AND PROGNOSTIC VALUES OF VIROLOGICAL AND CD4 CELL MEASURES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-INFECTED PATIENTS WITH 200-500 CD4 CELLS MM(3) (ACTG-175)/, The Journal of infectious diseases, 177(3), 1998, pp. 617-624
Authors:
FISCUS SA
HUGHES MD
LATHEY JL
PI T
JACKSON JB
RASHEED S
ELBEIK T
REICHMAN R
JAPOUR A
BYINGTON R
SCOTT W
GRIFFITH BP
KATZENSTEIN DA
HAMMER SM
Citation: Sa. Fiscus et al., CHANGES IN VIROLOGICAL MARKERS AS PREDICTORS OF CD4 CELL DECLINE AND PROGRESSION OF DISEASE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTEDADULTS TREATED WITH NUCLEOSIDES, The Journal of infectious diseases, 177(3), 1998, pp. 625-633
Authors:
HUGHES MD
JOHNSON VA
HIRSCH MS
BREMER JW
ELBEIK T
ERICE A
KURITZKES DR
SCOTT WA
SPECTOR SA
BASGOZ N
FISCHL MA
DAQUILA RT
Citation: Md. Hughes et al., MONITORING PLASMA HIV-1 RNA LEVELS IN ADDITION TO CD4(+) LYMPHOCYTE COUNT IMPROVES ASSESSMENT OF ANTIRETROVIRAL THERAPEUTIC RESPONSE, Annals of internal medicine, 126(12), 1997, pp. 929-938
Authors:
HARRER T
HARRER E
KALAMS SA
ELBEIK T
STAPRANS SI
FEINBERG MB
CAO YZ
HO DD
YILMA T
CALIENDO AM
JOHNSON RP
BUCHBINDER SP
WALKER BD
Citation: T. Harrer et al., STRONG CYTOTOXIC T-CELL AND WEAK NEUTRALIZING ANTIBODY-RESPONSES IN ASUBSET OF PERSONS WITH STABLE NONPROGRESSING HIV TYPE-1 INFECTION, AIDS research and human retroviruses, 12(7), 1996, pp. 585-592
Authors:
KATZENSTEIN DA
HAMMER SM
HUGHES MD
GUNDACKER H
JACKSON JB
FISCUS S
RASHEED S
ELBEIK T
REICHMAN R
JAPOUR A
MERIGAN TC
HIRSCH MS
Citation: Da. Katzenstein et al., THE RELATION OF VIROLOGICAL AND IMMUNOLOGICAL MARKERS TO CLINICAL OUTCOMES AFTER NUCLEOSIDE THERAPY IN HIV-INFECTED ADULTS WITH 200 TO 500 CD4 CELLS PER CUBIC MILLIMETER, The New England journal of medicine, 335(15), 1996, pp. 1091-1098
Authors:
HARRER T
HARRER E
KALAMS SA
BARBOSA P
TROCHA A
JOHNSON RP
ELBEIK T
FEINBERG MB
BUCHBINDER SP
WALKER BD
Citation: T. Harrer et al., CYTOTOXIC T-LYMPHOCYTES IN ASYMPTOMATIC LONG-TERM NONPROGRESSING HIV-1 INFECTION - BREADTH AND SPECIFICITY OF THE RESPONSE AND RELATION TO IN-VIVO VIRAL QUASI-SPECIES IN A PERSON WITH PROLONGED INFECTION AND LOW VIRAL LOAD, The Journal of immunology, 156(7), 1996, pp. 2616-2623
Authors:
HARTLEY CA
GILBERT MJ
BRIGIDO L
ELBEIK T
LEVY JA
CROWE SM
MILLS J
Citation: Ca. Hartley et al., HUMAN-IMMUNODEFICIENCY-VIRUS GROWN IN CD4-EXPRESSING CELLS IS ASSOCIATED WITH CD4, Journal of General Virology, 77, 1996, pp. 2015-2023
Authors:
CAVERT W
COOMBS RW
GRIMES J
KURITZKES D
JOHNSON V
KAPPES J
STEIN D
BEATTY C
ERICE A
WINTERS M
KATZENSTEIN D
JOHNSON E
ROJO E
MIRABILE M
ELBEIK T
TSIATIS B
COREY L
Citation: W. Cavert et al., THERAPEUTIC SIGNIFICANCE OF SWITCHING TO DIDANOSINE (DDI) OR ADDING DDI IN SUBJECTS WITH ZIDOVUIDINE-RESISTANT HIV-1, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 41-41
Citation: S. Safrin et al., A COMPARATIVE-EVALUATION OF 3 METHODS OF ANTIVIRAL SUSCEPTIBILITY TESTING OF CLINICAL HERPES-SIMPLEX VIRUS ISOLATES, Clinical and diagnostic virology, 4(1), 1995, pp. 81-91
Authors:
HAMILTON B
FOLLANSBEE S
STAPRANS S
ELBEIK T
FEINBERG M
Citation: B. Hamilton et al., INCREASED HIV PLASMA VIREMIA FOLLOWING INFLUENZA VACCINATION OF SEROPOSITIVE ADULTS, Journal of cellular biochemistry, 1995, pp. 207-207
Authors:
KAHN JO
STEIMER KS
BAENZIGER J
DULIEGE AM
FEINBERG M
ELBEIK T
CHESNEY M
MURCAR N
CHERNOFF D
SINANGIL F
Citation: Jo. Kahn et al., CLINICAL, IMMUNOLOGICAL, AND VIROLOGICAL OBSERVATIONS RELATED TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-I INFECTION IN A VOLUNTEER IN AN HIV-1 VACCINE CLINICAL-TRIAL, The Journal of infectious diseases, 171(5), 1995, pp. 1343-1347
Authors:
STAPRANS SI
HAMILTON BL
FOLLANSBEE SE
ELBEIK T
BARBOSA P
GRANT RM
FEINBERG MB
Citation: Si. Staprans et al., ACTIVATION OF VIRUS-REPLICATION AFTER VACCINATION OF HIV-1-INFECTED INDIVIDUALS, The Journal of experimental medicine, 182(6), 1995, pp. 1727-1737
Authors:
LATHEY JL
FISCUS SA
RASHEED S
KAPPES JC
GRIFFITH BP
ELBEIK T
SPECTOR SA
REICHELDERFER PS
Citation: Jl. Lathey et al., OPTIMIZATION OF QUANTITATIVE CULTURE ASSAY FOR HUMAN-IMMUNODEFICIENCY-VIRUS FROM PLASMA, Journal of clinical microbiology, 32(12), 1994, pp. 3064-3067
Authors:
SAFRIN S
ELBEIK T
PHAN LH
ROBINSON D
RUSH J
ELBAGGARI A
MILLS J
Citation: S. Safrin et al., CORRELATION BETWEEN RESPONSE TO ACYCLOVIR AND FOSCARNET THERAPY AND IN-VITRO SUSCEPTIBILITY RESULT FOR ISOLATES OF HERPES-SIMPLEX VIRUS FROM HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS, Antimicrobial agents and chemotherapy, 38(6), 1994, pp. 1246-1250
Citation: S. Safrin et al., A RAPID SCREEN TEST FOR IN-VITRO SUSCEPTIBILITY OF CLINICAL HERPES-SIMPLEX VIRUS ISOLATES, The Journal of infectious diseases, 169(4), 1994, pp. 879-882
Authors:
PACHL C
ELBEIK T
SAXER M
KERN D
STEMPEIN M
FONG SJ
SHERIDAN P
YEGHIAZARIAN T
NEUWALD P
URDEA M
FEINBERG M
TODD J
Citation: C. Pachl et al., QUANTITATION OF HIV-1 RNA IN PLASMA USING A SIGNAL AMPLIFICATION BRANCHED DNA (BDNA) ASSAY, Journal of cellular biochemistry, 1993, pp. 20-20